David Beier

David Beier - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock David Beier’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Investor type
Country
City/Area
Stages

-

Contacts
fir***@***.com Available after registration.
Markets
Past investments
DermiraPhenomixNuPatheCydanTRIA BeautySynGenVivaldi BiosciencesPTC TherapeuticsSunesis PharmaceuticalsEpizymeHyperion TherapeuticsAvera PharmaceuticalOculisAltheosAscendancyVIA PharmaceuticalsUCSF Benioff Children's Hospital OaklandXeris PharmaceuticalsBrainCellsImaraAragon SurgicalOculex PharmaceuticalsVice President of the Unites StatesReliant PharmaceuticalsCymaBay TherapeuticsNextWave PharmaceuticalsNevroNextCureIDEV TechnologiesAccriva DiagnosticsInterleukin GeneticsEpocratesAviirSteinberg InstitutePharmionAciex TherapeuticsNabsysCalifornia Life Sciences Association (CLSA)Ion TorrentCivitas TherapeuticsFabric Genomics (formerly Omicia)Xilio TherapeuticsVtesseRadiant MedicalEnteroMedicsCadence PharmaceuticalsConatus PharmaceuticalsGossamer BioCalypso MedicalVYNE TherapeuticsKBP BiosciencesMerusPresidio PharmaceuticalsGritstone OncologyNBI DevelopmentPharmAkea TherapeuticsTwist BioscienceKezar Life SciencesBay City CapitalIterum TherapeuticsArcus BiosciencesMAP Pharmaceuticals
Investor Profile

David Beier is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Dermira, Phenomix, NuPathe, Cydan, TRIA Beauty, SynGen, Vivaldi Biosciences, PTC Therapeutics, Sunesis Pharmaceuticals, Epizyme, Hyperion Therapeutics, Avera Pharmaceutical, Oculis, Altheos, Ascendancy, VIA Pharmaceuticals, UCSF Benioff Children's Hospital Oakland, Xeris Pharmaceuticals, BrainCells, Imara, Aragon Surgical, Oculex Pharmaceuticals, Vice President of the Unites States, Reliant Pharmaceuticals, CymaBay Therapeutics, NextWave Pharmaceuticals, Nevro, NextCure, IDEV Technologies, Accriva Diagnostics, Interleukin Genetics, Epocrates, Aviir, Steinberg Institute, Pharmion, Aciex Therapeutics, Nabsys, California Life Sciences Association (CLSA), Ion Torrent, Civitas Therapeutics, Fabric Genomics (formerly Omicia), Xilio Therapeutics, Vtesse, Radiant Medical, EnteroMedics, Cadence Pharmaceuticals, Conatus Pharmaceuticals, Gossamer Bio, Calypso Medical, VYNE Therapeutics, KBP Biosciences, Merus, Presidio Pharmaceuticals, Gritstone Oncology, NBI Development, PharmAkea Therapeutics, Twist Bioscience, Kezar Life Sciences, Bay City Capital, Iterum Therapeutics, Arcus Biosciences, MAP Pharmaceuticals, . Over time, David Beier has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Beier is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Customer Service, Parks, Wellness, Women Founded, Enterprise Software, Infrastructure, Transportation, Public Policy, Life Science, Engineering, Education, Senior Care, Science, Finance, Software, Biotechnology, Business Management, Genomics, Innovation, Consumer Software, Health Diagnostics, Renewable Energy, Medical, Information Technology, B2B, Real Estate, Therapeutics, Pharmaceuticals, Mental Health may find it worthwhile to explore potential connections with David Beier, as their portfolio suggests a familiarity and interest in this area.

Understanding David Beier’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today